Brand Engagement Network Completes Acquisition of Cataneo, 2025 Revenue Exceeds €8.6M
Brand Engagement Network completed its acquisition of Cataneo, an enterprise software provider that generated more than EUR 8.6M in 2025 revenue and whose platform manages more than EUR 6B in annual advertising inventory across more than 1,000 media brands and 200+ broadcast and digital channels. The company said, "Cataneo, a Munich-based provider of enterprise software for advertising operations and infrastructure, operates the MYDAS platform, which supports advertising sales, scheduling, traffic, content management, monetization, analytics, CRM integration, and real-time reporting for broadcasters and media organizations worldwide. The acquisition provides BEN with an established enterprise software platform, long-standing customer relationships, and mission-critical workflows where its AI technologies can be integrated and deployed. The acquisition of Cataneo enhances BEN's ability to embed enterprise AI into real-world operational environments across the media and advertising ecosystem, strengthening its position as an enterprise AI software provider. The strategic value of the acquisition is twofold. First, BEN intends to integrate its proprietary Engagement Language Model and enterprise AI technologies into the Cataneo platform to enhance advertising operations, audience intelligence, workflow automation, forecasting, and operational decision-making. Second, Cataneo provides an established commercial platform through which BEN can deploy AI-powered enterprise solutions to existing customers while expanding into additional industries over time." As part of the transaction, Cataneo Co-Founder Christian Unterseer has joined BEN's Board of Directors. Integration efforts are now underway, with both organizations continuing to support customers without disruption.
Trade with 70% Backtested Accuracy
Analyst Views on BNAI
About BNAI
About the author

- Acquisition Overview: Brand Engagement Network (BNAI) completed its acquisition of Cataneo GmbH on June 30, 2026, with Cataneo generating over €8.6 million in revenue in 2025, thereby enhancing BNAI's market position in enterprise AI software.
- Platform Integration: Cataneo's MYDAS platform manages over €6 billion in advertising inventory, and BNAI plans to integrate its proprietary Engagement Language Model (ELM™) into the Cataneo platform to enhance advertising operations and decision-making efficiency, further promoting the application of enterprise AI.
- Strengthened Customer Relationships: The acquisition not only provides BNAI with long-standing customer relationships and critical workflows but also enables it to promote AI-driven enterprise solutions among existing customers while expanding into other industries, thereby enhancing market competitiveness.
- Leadership Changes: Cataneo co-founder Christian Unterseer has joined BNAI's Board of Directors, with integration efforts underway to ensure uninterrupted customer service, demonstrating BNAI's commitment to continuous innovation and customer support.
- Acquisition Overview: Brand Engagement Network (BNAI) completed its acquisition of Cataneo GmbH on June 30, 2026, with Cataneo generating over €8.6 million in revenue in 2025 and managing more than €6 billion in advertising inventory, thereby enhancing BNAI's market position in the global advertising and media sector.
- Technology Integration: The acquisition aims to integrate BNAI's proprietary Engagement Language Model (ELM™) with Cataneo's platform to enhance advertising operations, audience intelligence, and workflow automation, thereby driving the application of enterprise AI within the advertising ecosystem.
- Customer Base Expansion: Cataneo's established commercial platform provides BNAI with a channel to deploy AI solutions to existing customers while creating opportunities for future expansion into other industries, which is expected to further enhance customer retention and revenue stability.
- Leadership Changes: Cataneo co-founder Christian Unterseer has joined BNAI's Board of Directors, with integration efforts underway to ensure uninterrupted customer service, indicating that the synergy between the two companies will deliver greater value to clients.
- Clinical Evaluation Progress: Following the successful completion of Phase 1 rheumatology testing, Skye Salud has advanced to Phase 2 evaluation, which aims to expand testing into primary care use cases, expected to significantly enhance the platform's ability to access clinical information across Mexico and Latin America.
- AI Technology Application: The platform leverages BEN's enterprise-grade AI capabilities, Grupo Skye's innovative leadership in Latin America, and KNOBLOCH Information Group's trusted relationships within Mexico's healthcare community, aiming to optimize the retrieval of medical evidence through AI to improve service efficiency and quality.
- Market Opportunity: As one of the largest healthcare markets in Latin America, Mexico presents a significant opportunity for evaluating AI-enabled access to medical evidence, with the Phase 2 expansion expected to provide critical insights for future product development and commercialization planning.
- Strategic Collaboration: The collaboration among BEN, Grupo Skye, and KNOBLOCH Information Group creates a unique opportunity to evaluate how trusted medical evidence can be accessed more efficiently through AI while ensuring transparency and rigorous evidence standards, driving innovation in the healthcare sector.
- Clinical Evaluation Progress: Following the successful completion of Phase 1 rheumatology testing, Skye Salud has advanced to Phase 2 evaluation, aimed at expanding testing into primary care use cases, which is expected to enhance the platform's performance and applicability across a broader range of clinical topics.
- AI Technology Application: The platform leverages BEN's enterprise-grade AI capabilities, Grupo Skye's leadership in AI innovation across Latin America, and KNOBLOCH's trusted relationships within Mexico's healthcare community to optimize access to medical evidence through AI, thereby improving the accessibility of clinical information.
- Market Potential: As one of the largest healthcare markets in Latin America, Mexico presents a significant opportunity for evaluating AI-enabled access to medical evidence, with the Phase 2 expansion set to provide valuable insights for future product development and commercialization planning.
- Strategic Collaboration: The partnership among BEN, Grupo Skye, and KNOBLOCH not only provides an evaluation framework for the platform's clinical coverage and evidence support capabilities but also ensures that stringent evidence standards and transparency are maintained during the expansion, reflecting a long-term commitment to the healthcare industry.
- Russell 3000 Inclusion: Brand Engagement Network (BNAI) announced its selection for membership in the Russell 3000 index as part of the 2026 Russell U.S. Indexes reconstitution, effective at the close of U.S. markets on June 26, 2026, which is expected to enhance the company's visibility and market recognition among investors.
- Market Capitalization Ranking: The annual Russell U.S. Indexes reconstitution evaluates the largest U.S. stocks as of April 30 and ranks them by total market capitalization, indicating BNAI's relative strength in the market and potentially attracting more institutional investor interest.
- Financial Performance Concerns: Despite BNAI's inclusion in a significant index, its revenue remains minimal while dilution continues to rise, which could negatively impact long-term shareholder value, prompting investors to monitor improvements in profitability.
- Acquisition Strategy: BNAI plans to acquire Cataneo for $19.5 million, which may provide new growth opportunities for the company, but it also raises concerns regarding the challenges of post-acquisition integration and its impact on financial health.
- Inclusion in Russell 3000: Brand Engagement Network Inc. (BNAI) has been selected for membership in the 2026 Russell U.S. Indexes reconstitution, effective at the close of U.S. markets on June 26, 2026, marking a significant milestone in the company's public journey.
- Market Coverage Expansion: The Russell 3000 Index includes approximately 3,000 of the largest U.S. public companies, representing about 98% of the investable U.S. equity market, and BEN's inclusion will significantly enhance its visibility among investors.
- Technological Edge: BEN focuses on providing secure, enterprise-grade AI solutions for regulated industries such as healthcare and financial services, aiming to connect organizations, brands, and consumers through intelligent experiences that drive meaningful outcomes.
- Investor Confidence Boost: CEO Tyler Luck stated that joining the Russell indexes not only enhances the company's market image but also strengthens interactions with institutional investors, further driving the company's long-term growth strategy.








